Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v4-EN
Language French English
Date Updated 2025-03-17 2025-03-10
Drug Identification Number 02384124 02384124
Brand name FENTANYL CITRATE INJECTION SDZ FENTANYL CITRATE INJECTION SDZ
Common or Proper name FENTANYL CITRATE INJECTION FENTANYL CITRATE INJECTION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients FENTANYL FENTANYL
Strength(s) 50MCG 50MCG
Dosage form(s) SOLUTION LIQUID SOLUTION LIQUID
Route of administration EPIDURAL INTRAVENOUS INTRAMUSCULAR EPIDURAL INTRAVENOUS INTRAMUSCULAR EPIDURAL INTRAVENOUS INTRAMUSCULAR EPIDURAL INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 2ML 2ML
ATC code N01AH N01AH
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2025-03-03 2025-03-03
Estimated end date 2025-03-28 2025-03-28
Actual end date 2025-03-17
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments